Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
Date:10/7/2008

AUSTIN, Texas, Oct. 7 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has been selected as one of only a few sites in the nation to participate in an FDA-approved clinical trial for a new device to treat persistent atrial fibrillation. TCAI, an international treatment, training and research center specializing in heart rhythm disorders, is a partnership between St. David's Medical Center and Texas Cardiovascular Consultants.

"This is just another example of how TCAI is leading the nation in pioneering new treatments for atrial fibrillation," Dr. Rodney Horton, electrophysiologist, Texas Cardiac Arrhythmia, said. "We are proud to take part in this study that has the potential to greatly enhance the future treatment of A Fib."

Heart arrhythmias are very common, affecting more than two million people nationwide. Atrial fibrillation, or A Fib, is the most common heart arrhythmia. A Fib is a rhythm disorder that affects the electrical system, or "wiring," of the heart muscle. It is often treated with cardiac ablation -- a procedure that allows physicians to deliver energy directly to the heart muscle at precise points that trigger the arrhythmia, creating a lesion that blocks the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation of a more effective lesion.

"In the Gen II study, we are evaluating a revolutionary radiofrequency ablation catheter," Dr. Horton said. "This device is able to monitor the temperature at its tip, giving electrophysiologists the ability to better control the delivery of energy through the catheter and generate a more effective lesion." In traditional cardiac ablation, room temperature saline is injected through the catheter prior to the delivery of energy. Because standard catheters do not measure the temperature at the catheter's tip, overheating may occur, resulting in th
'/>"/>

SOURCE The Texas Cardiac Arrhythmia Institute at St. David?sMedical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
2. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
3. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
4. Personalized Medicine - The Genomic Revolution in Cardiac Care
5. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
6. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
7. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
8. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
9. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
10. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
11. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- On September 25 to 26, 2014, ... and manufacturing - MEDTEC China  - will mark its ... Convention Center, bringing together close to 300 leading global ... latest medical-grade raw materials, parts and processing technologies. ... free visitor pre-registration to be completed. To date, more ...
(Date:9/16/2014)... , Sept. 16, 2014 Northwest Biotherapeutics (NASDAQ: ... developing DCVax® personalized immune therapies for solid tumor cancers, ... to receive formal designation as a "Promising Innovative Medicine" ... (EAMS) launched in the UK in April 2014.  A ... for early access approval under the EAMS.  ...
(Date:9/16/2014)... 2014  Synereca Pharmaceutics, Inc. (SPI), a ... drugs that restore or increase the effectiveness ... million convertible debt financing. Accele Venture Partners, ... Accele Biopharma, Inc., led the financing with ... private not-for-profit corporation focused on growing innovative ...
Breaking Medicine Technology:MEDTEC China 2014: Seven Highlights Not to Miss! 2MEDTEC China 2014: Seven Highlights Not to Miss! 3MEDTEC China 2014: Seven Highlights Not to Miss! 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 2NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 3NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 4NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM) 5Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4
... France, July 10 Ipsogen SA,(Alternext: ALIPS) today reported ... Therapy of Early Breast Cancer indicated for the first,time ... adjunct to the,histological grade. These new guidelines, published online ... European and US experts on,early breast cancer treatment that ...
... , KENILWORTH, N.J., July 9 Schering-Plough Corporation (NYSE: ... the company,s country operation in Japan, has received marketing ... for the treatment of bronchial asthma in adults.(1) , ... of the ASMANEX TWISTHALER in Japan," said Thomas P. ...
Cached Medicine Technology:Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer 2Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting on the Primary Treatment of Early Breast Cancer 3ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 2ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 3ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients 4
(Date:9/16/2014)... the right balance of nitrogen, phosphorus and potassium is ... State University study finds. , A review of data ... other regions showed that high yields were linked to ... nutrients at specific ratios - nitrogen and phosphorus at ... a ratio of 1-to-1. These nutrient uptake ratios were ...
(Date:9/16/2014)... PA (PRWEB) September 16, 2014 AcousticSheep ... are preparing to launch RunPhones® Wireless, their latest version ... inside a sport-style headband for active people seeking a ... sport headphones on the market and will be ... new RunPhones® Wireless has all of the same great ...
(Date:9/16/2014)... Tara Haelle HealthDay ... -- About 14.5 million U.S. cancer survivors are alive ... American Association for Cancer Research reported Tuesday. These ... include nearly 380,000 survivors of childhood cancer, according to ... in prevention, identification, research and treatment of cancer and ...
(Date:9/16/2014)... September 16, 2014 Novatus, a leading ... new office in London, UK, and appointed Jim Curran ... Europe, the expansion will allow Novatus to target growing ... European customers. , “Novatus is excited ... London is an ideal location to establish our European ...
(Date:9/16/2014)... DC September 16, 2014 The ... coherence tomography (OCT) in primary percutaneous coronary ... annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. ... TCT is the world,s premier educational meeting ... OCT uses light emitted from an intravascular ...
Breaking Medicine News(10 mins):Health News:Boosting global corn yields depends on improving nutrient balance 2Health News:Boosting global corn yields depends on improving nutrient balance 3Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 2Health News:RunPhones® Prepares to Launch Their New Highly Anticipated Wireless Headphones 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 4Health News:Novatus Expands European Operations with a New Office in London 2Health News:Results of OCT STEMI trial reported at TCT 2014 2
... to lead Diabetes Sales, Managed Care and Government ... ... Novo Nordisk, a,healthcare company with an 85-year history of innovation ... Pamela Harris as,vice president for Diabetes Sales, Managed Care and ...
... Two-Week Eye Health Program,in Mandalay, NEW YORK, Feb. ... and the Mandalay Eye and ENT Hospital, ORBIS,International, a ... to Myanmar to conduct its ninth Flying Eye,Hospital program ... February,25 to March 7, 2008., Working together with ...
... drive to digitize data creates need for 99.999% ... ... virtually all healthcare,record keeping and patient care functions converting to ... grade" servers that provide the extreme reliability healthcare,practices need to ...
... rarely detected before it has grown large enough to impair ... disease to fight, especially since chemotherapy is not very effective. ... Faingold may open the door for very promising new treatment ... the cover of the February 2008 issue of Clinical Cancer ...
... Frank E. Staggers, Sr.,M.D. of Oakland, Calif., is a ... Excellence in Volunteerism. Presented by the American Medical,Association (AMA) ... commitment to volunteer medical care to those without access,to ... the award in,association with the Pfizer Medical Humanities Initiative., ...
... Joyce D. Kirkland Essien,M.D., M.B.A., of Atlanta, is ... Presented by the American Medical Association (AMA),Foundation, the award ... the U.S. The AMA Foundation presents the award in,association ... will be presented on Monday, March 31st, at the ...
Cached Medicine News:Health News:Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President 2Health News:ORBIS International's Flying Eye Hospital Returns to Myanmar 2Health News:Stratus Medical Grade Servers Deliver 24/7 Online Information Access and Application Availability 2Health News:Stratus Medical Grade Servers Deliver 24/7 Online Information Access and Application Availability 3Health News:HSP90: New point of view on melanoma of the eye, at the MUHC 2Health News:AMA Foundation Honors Oakland, California Physician for Volunteerism 2Health News:AMA Foundation Honors Atlanta Physician for Increasing Access to Health Care in the U.S. 2
... System is a point-of-care system designed for ... referred to as Platelet Rich Plasma - ... a small sample of blood. The Symphony ... factors, which are found in the platelets. ...
... Dual Imaging Color Module Leica combines precision microscopy ... important and necessary patient data can be displayed ... optical platform on the Leica OH3, OHS1, MS3 ... highest brightness, contrast >300:1, true color and resolution ...
... Headlight mounted micro video camera has ... pictures in areas otherwise invisible to all ... capabilities. The system may be used for ... eliminating crowding of the sterile area and ...
... DXC-S500 consists of 2-piece body, one is CHU ... and built-in Peltier cooling devices, the other is ... monitor. CCU incorporates IEEE1394 interface for direct connection ... card slot for storing images into memory stick ...
Medicine Products: